Dan Hart

Inhibitor development and mortality in non‐severe hemophilia A

Corien L. Eckhardt, J.I. Loomans, Alice S. van Velzen et al. · Journal of Thrombosis and Haemostasis · 2015 · 76 citations · Full text

Medicine, Hematology, Pharmacology +16

Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome

Matthew C. Sims, Louisa Mayer, Janine Collins et al. · Blood · 2020 · 60 citations · Full text

Medicine, Hematology, Immunology +17

Common themes and challenges in hemophilia care: a multinational perspective

Jayson Stoffman, Nadine G. Andersson, Brian R. Branchford et al. · Hematology · 2018 · 25 citations · Full text

Nursing, Health Policy, Hematology +16

The factor VIII treatment history of non‐severe hemophilia A

Amal Abdi, Fabienne R. Kloosterman, Corien L. Eckhardt et al. · Journal of Thrombosis and Haemostasis · 2020 · 24 citations · Full text

Medicine, Hematology, Clinical Epidemiology +15

Treatment‐related risk factors for inhibitor development in non‐severe hemophilia A after 50 cumulative exposure days: A case‐control study

Amal Abdi, Corien L. Eckhardt, Alice S. van Velzen et al. · Journal of Thrombosis and Haemostasis · 2021 · 15 citations · Full text

Medicine, Hematology, Pharmacology +12